Prime Highlights:
- Green Park Pharma receives £500,000 investment to expand operations and develop new medicines.
- The company plans to create 10 new jobs over the next three years to support growth.
Key Facts:
- The funding is part of a £2.2 million early-stage funding round, with the potential for an additional £4.5 million in later stages.
- The company’s patented liquid medicine technology helps patients who struggle to swallow tablets by producing stable, ready-to-use medicines that last longer and don’t require refrigeration.
Background:
Cornwall-based pharmaceutical firm Green Park Pharma is set to accelerate its growth after securing £500,000 in equity funding from the British Business Bank’s South West Investment Fund, managed by The FSE Group. The investment is part of a £2.2 million early funding round, with the possibility of up to £4.5 million more in later stages.
The funding will help Green Park Pharma hire 10 new staff over the next three years and develop more liquid medicines for patients who have trouble swallowing tablets.
Richard Reavley, CEO of Green Park Pharma Group, explained that many people, including children and adults with conditions like stroke, dementia, or certain cancers, have trouble swallowing tablets. He said the company’s liquid medicines are easy to use, stable at room temperature, and last a long time, helping patients take the right dose and making life easier for healthcare providers. He added that the new funding will support the company’s growth and global impact.
Green Park Pharma has already helped bring more than 40 products to market worldwide. Green Park Pharma’s patented technology turns medicines that are usually solid into ready-to-use liquid forms. These liquids are stable, can be stored at room temperature, and last longer than regular liquid medicines, making them easier for patients and healthcare workers to use.
Anna Staevska, Investment Manager at The FSE Group, said: “Green Park Pharma has a strong business model and innovative technology. This funding will help the company grow quickly and reach the market faster, and we are excited to support them.”
The South West Investment Fund can provide equity investments up to £5 million to help small businesses grow. The British Business Bank says it is committed to backing high-growth, innovative companies like Green Park Pharma that meet real medical needs.
